Daniel E. Bauer
8Patents
1h-index
15Co-inventors
44Inventor score
Filing activity: May 7, 2004 → Sep 17, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9822355B2 | Targeting BCL11A distal regulatory elements for fetal hemoglobin reinduction | Chemistry; Metallurgy | 6 | Active |
| US10472619B2 | Targeting BCL11A distal regulatory elements for fetal hemoglobin reinduction | Chemistry; Metallurgy | 0 | Active |
| US11685917B2 | Functional genomics using CRISPR-Cas systems for saturating mutagenesis of non-coding elements, compositions, methods, libraries and applications thereof | Chemistry; Metallurgy | 0 | Active |
| US9060993B2 | Compositions and methods for treating cancer | Human Necessities | 0 | Active |
| US11788087B2 | BCL11A guide delivery | Chemistry; Metallurgy | 0 | Active |
| US12098363B2 | Targeting BCL11A distal regulatory elements with a CAS9-CAS9 fusion for fetal hemoglobin reinduction | Chemistry; Metallurgy | 0 | Active |
| US11542493B2 | Targeting BCL11A distal regulatory elements for fetal hemoglobin reinduction | Chemistry; Metallurgy | 0 | Active |
| US11572543B2 | Targeting BCL11A enhancer functional regions for fetal hemoglobin reinduction | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.